Haroonrashid M. Hattiwale

Dr. Haroonrashid M. Hattiwale


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2024 in Tissue and Cell
Verified
Journal Article
Closed access
APAyyub Ali Patel
Ayyub Ali Patel
AMAsma'A H. Mohamed
Asma'A H. Mohamed
JRJasur Rizaev
Jasur Rizaev
AMAyaz Khurram Mallick
Ayaz Khurram Mallick
MQMaytham T. Qasim
Maytham T. Qasim
FAFuzail Ahmad
Fuzail Ahmad

12 May 2025 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
MJMohammad Chand Jamali
Mohammad Chand Jamali
AMAsma’a H. Mohamed
Asma’a H. Mohamed
AJAzfar Jamal
Azfar Jamal
MKMohammad Azhar Kamal
Mohammad Azhar Kamal
WAWaleed Al Abdulmonem
Waleed Al Abdulmonem
HHHaroonrashid M. Hattiwale
Haroonrashid M. Hattiwale
Allergic diseases significantly impact the quality of life of people around the world. Cytokines play a crucial role in regulating the immune system. Due to their importance in pro-inflammatory mechanisms, cytokines are used to understand pathogenesis and serve as biomarkers in many diseases. One such cytokine is interleukin-33, a member of the IL-1 family, including IL- 1α, IL-1β, and IL-18. The IL-33 receptor is a heterodimer of IL-1 receptor-like 1 and IL-1 receptor accessory protein. IL-33 plays a critical role in regulating innate and adaptive immune responses. The primary targets of IL-33 in vivo are tissue-resident immune cells, including mast cells, group 2 innate lymphoid cells, regulatory T cells, T helper 2 cells, eosinophils, basophils, dendritic cells, Th1 cells, CD8 + T cells, NK cells, iNKT cells, B cells, neutrophils, and macrophages. However, IL-33 appears to act as an alarm signal that is promptly released by producing cells under cellular damage or stress conditions. IL-33 regulates signaling and various biological functions, including induction of pro-inflammatory cytokines, regulation of cell proliferation, and involvement in tissue remodeling. IL-33 is fundamental in immune-related diseases and plays a critical role in the control of inflammation. Recently, IL-33 has been shown to significantly impact allergic diseases, primarily by inducing Th2 immune responses. IL-33 is a key regulator of mast cell function and a promising therapeutic target for treating allergic diseases. This review provides an overview of the current understanding of the role of IL-33 in allergy pathogenesis and potential clinical approaches.

6 September 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
AJazfar jamal
azfar jamal
MKMohammad Azhar Kamal
Mohammad Azhar Kamal
YAYaser E. Alqurashi
Yaser E. Alqurashi
EAEsam S. Al-Malki
Esam S. Al-Malki
MNMohammed M. Naiyer
Mohammed M. Naiyer
HHHaroonrashid M. Hattiwale
Haroonrashid M. Hattiwale

29 June 2026 in Pathology - Research and Practice
Verified
Journal Article
Closed access
AHAtahar Husein
Atahar Husein
AJazfar jamal
azfar jamal
RARahat Ali
Rahat Ali
MKMOHAMMAD AZHAR KAMAL
MOHAMMAD AZHAR KAMAL
YAYaser E. Alqurashi
Yaser E. Alqurashi
HHHaroonrashid M. Hattiwale
Haroonrashid M. Hattiwale